Jane Wasman - May 30, 2025 Form 4 Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
Director
Signature
/s/ Jane Wasman
Stock symbol
SLS
Transactions as of
May 30, 2025
Transactions value $
$33,800
Form type
4
Date filed
6/2/2025, 04:42 PM
Previous filing
May 28, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wasman Jane Director C/O SELLAS LIFE SCIENCES GROUP, INC.,, 7 TIMES SQUARE, SUITE 2503, NEW YORK /s/ Jane Wasman 2025-06-02 0001352455

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLS Common Stock Purchase $33.8K +20K +192.31% $1.69 30.4K May 30, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple transactions at a price of $1.69. The reporting person undertakes to provide SELLAS Life Sciences Group, Inc., any security holder of SELLAS Life Sciences Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at the price set forth in this footnote.